Άρθρα με εντολές δημόσιας πρόσβασης - Carsten DenkertΜάθετε περισσότερα
ΣύνολοNIHBMBFEuropean CommissionDFGCancer Research UKSusan G. KomenNHMRCMRCNIHRDoDANRBreast Cancer Now, UKSCLVAHEAGovernment of SpainKWFSFIEPSRCHFSPCCSBanking Foundation "la Caixa"Academy of FinlandOTKANWOWellcomeNKFIRoyal Society UKFWOFraunhofer-GesellschaftINSERMHRBKnut and Alice Wallenberg FoundationVersus Arthritis, UKLeducq Foundation, USAOICR
Δεν είναι διαθέσιμο πουθενά: 8
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
P Savas, R Salgado, C Denkert, C Sotiriou, PK Darcy, MJ Smyth, S Loi
Nature reviews Clinical oncology 13 (4), 228-241, 2016
Εντολές: National Health and Medical Research Council, Australia, Susan G. Komen
MALDI‐imaging for classification of epithelial ovarian cancer histotypes from a tissue microarray using machine learning methods
O Klein, F Kanter, H Kulbe, P Jank, C Denkert, G Nebrich, WD Schmitt, ...
PROTEOMICS–Clinical Applications 13 (1), 1700181, 2019
Εντολές: Federal Ministry of Education and Research, Germany
Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance
K Berns, A Sonnenblick, A Gennissen, S Brohée, EM Hijmans, B Evers, ...
Clinical Cancer Research 22 (21), 5238-5248, 2016
Εντολές: Netherlands Organisation for Scientific Research, Dutch Cancer Society
Cancer beyond organ and tissue specificity: next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers
D Heim, J Budczies, A Stenzinger, D Treue, P Hufnagl, C Denkert, ...
International journal of cancer 135 (10), 2362-2369, 2014
Εντολές: Human Frontier Science Program
Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant GeparSepto trial
S Loibl, D Treue, J Budczies, K Weber, A Stenzinger, WD Schmitt, ...
Clinical Cancer Research 25 (13), 3986-3995, 2019
Εντολές: Federal Ministry of Education and Research, Germany
Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors
J Budczies, M Bockmayr, F Klauschen, V Endris, S Fröhling, ...
Genes, Chromosomes and Cancer 56 (8), 651-659, 2017
Εντολές: Federal Ministry of Education and Research, Germany
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the …
M Sinn, BV Sinn, D Treue, U Keilholz, F Damm, R Schmuck, P Lohneis, ...
Clinical Cancer Research 26 (14), 3732-3739, 2020
Εντολές: Federal Ministry of Education and Research, Germany
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII+ IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a …
C Denkert, J Budczies, MM Regan, S Loibl, P Dell’Orto, G von Minckwitz, ...
Breast cancer research and treatment 176, 557-568, 2019
Εντολές: US National Institutes of Health, Susan G. Komen
Διαθέσιμο κάπου: 101
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ...
Annals of oncology 25 (8), 1544-1550, 2014
Εντολές: National Health and Medical Research Council, Australia, Susan G. Komen
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
Εντολές: US National Institutes of Health, Cancer Research UK
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
J Budczies, F Klauschen, BV Sinn, B Győrffy, WD Schmitt, ...
PloS one 7 (12), e51862, 2012
Εντολές: Hungarian Scientific Research Fund
Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2–positive and triple-negative …
C Denkert, G Von Minckwitz, JC Brase, BV Sinn, S Gade, R Kronenwett, ...
Journal of clinical oncology 33 (9), 983-991, 2015
Εντολές: European Commission
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
C Denkert, C Liedtke, A Tutt, G von Minckwitz
The Lancet 389 (10087), 2430-2442, 2017
Εντολές: Federal Ministry of Education and Research, Germany
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
Εντολές: US National Institutes of Health, Government of Spain
Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers
S Loi, D Drubay, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ...
Journal of clinical oncology 37 (7), 559-569, 2019
Εντολές: US National Institutes of Health, Agence Nationale de la Recherche, Swiss …
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
Εντολές: US National Institutes of Health
Tumor-infiltrating lymphocytes and associations with pathological complete response and event-free survival in HER2-positive early-stage breast cancer treated with lapatinib …
R Salgado, C Denkert, C Campbell, P Savas, P Nuciforo, C Aura, ...
JAMA oncology 1 (4), 448-455, 2015
Εντολές: US National Institutes of Health, National Health and Medical Research …
Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group
TO Nielsen, SCY Leung, DL Rimm, A Dodson, B Acs, S Badve, C Denkert, ...
JNCI: Journal of the National Cancer Institute 113 (7), 808-819, 2021
Εντολές: US National Institutes of Health
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
Εντολές: US National Institutes of Health, Susan G. Komen
Comparison of the performance of 6 prognostic signatures for estrogen receptor–positive breast cancer: a secondary analysis of a randomized clinical trial
I Sestak, R Buus, J Cuzick, P Dubsky, R Kronenwett, C Denkert, S Ferree, ...
JAMA oncology 4 (4), 545-553, 2018
Εντολές: US National Institutes of Health, Cancer Research UK, National Institute for …
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή